RAMONA KIANI: Open Payments
NPI 1861843765 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 34 payments from 15 companies in 2025. Trend: 2023 $331 · 2024 $429 · 2025 $653
Food & beverage: $592Education: $61
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $175 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $61 |
| PFIZER INC. | 3 | $56 |
| KYOWA KIRIN, INC. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Lilly USA, LLC | 2 | $34 |
| UCB, Inc. | 2 | $30 |
| Galderma Laboratories, L.P. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: BOTOX, DUPIXENT, SKYRIZI, CIBINQO, POTELIGEO, COSENTYX, Bimzelx, NEMLUVIO.
Industry payments across AZ — which companies pay providers there.
